Heat Stroke |
INTRODUCTION
Background:
Heat illness may be viewed as a continuum of illnesses relating to the
body’s inability to cope with heat. It includes minor illnesses, such as heat
edema, heat rash (ie, prickly heat), heat cramps, and tetany, as well as heat
syncope and heat exhaustion. Heat stroke is the most severe form of the
heat-related illnesses and is defined as a body temperature higher than 41.1°C
(106°F) associated with neurologic dysfunction.
Two forms of heat stroke exist. Exertional heat stroke (EHS) generally occurs
in young individuals who engage in strenuous physical activity for a prolonged
period of time in a hot environment. Classic nonexertional heat stroke (NEHS)
more commonly affects sedentary elderly individuals, persons who are chronically
ill, and very young persons. Classic NEHS occurs during environmental heat waves
and is more common in areas that have not experienced a heat wave in many years.
Both types of heat stroke are associated with a high morbidity and mortality,
especially when therapy is delayed.
Because behavioral responses are important in the management of temperature
elevations, heat stroke may be entirely preventable.
Pathophysiology: Despite wide variations in ambient
temperatures, humans and other mammals can maintain a constant body temperature
by balancing heat gain with heat loss. When heat gain overwhelms the body’s
mechanisms of heat loss, the body temperature rises, and a major heat illness
ensues. Excessive heat denatures proteins, destabilizes phospholipids and
lipoproteins, and liquefies membrane lipids, leading to cardiovascular collapse,
multiorgan failure, and, ultimately, death. The exact temperature at which
cardiovascular collapse occurs varies among individuals because coexisting
disease, drugs, and other factors may contribute to or delay organ dysfunction.
Full recovery has been observed in patients with temperatures as high as 46°C,
and death has occurred in patients with much lower temperatures. Temperatures
exceeding 106°F or 41.1°C generally are catastrophic and require immediate
aggressive therapy.
Heat may be acquired by a number of different mechanisms. At rest, basal
metabolic processes produce approximately 100 kcal of heat per hour or 1
kcal/kg/h. These reactions can raise the body temperature by 1.1°C/h if the heat
dissipating mechanisms are nonfunctional. Strenuous physical activity can
increase heat production more than 10-fold to levels exceeding 1000 kcal/h.
Similarly, fever, shivering, tremors, convulsions, thyrotoxicosis, sepsis,
sympathomimetic drugs, and many other conditions can increase heat production,
thereby increasing body temperature.
The body also can acquire heat from the environment through some of the same
mechanisms involved in heat dissipation, including conduction, convection, and
radiation. These mechanisms occur at the level of the skin and require a
properly functioning skin surface, sweat glands, and autonomic nervous system,
but they also may be manipulated by behavioral responses. Conduction refers to
the transfer of heat between 2 surfaces with differing temperatures that are in
direct contact. Convection refers to the transfer of heat between the body’s
surface and a gas or fluid with a differing temperature. Radiation refers to the
transfer of heat in the form of electromagnetic waves between the body and its
surroundings. The efficacy of radiation as a means of heat transfer depends on
the angle of the sun, the season, and the presence of clouds, among other
factors. For example, during summer, lying down in the sun can result in a heat
gain of up to 150 kcal/h.
Under normal physiologic conditions, heat gain is counteracted by a
commensurate heat loss. This is orchestrated by the hypothalamus, which
functions as a thermostat, guiding the body through mechanisms of heat
production or heat dissipation, thereby maintaining the body temperature at a
constant physiologic range. In a simplified model, thermosensors located in the
skin, muscles, and spinal cord send information regarding the core body
temperature to the anterior hypothalamus, where the information is processed and
appropriate physiologic and behavioral responses are generated. Physiologic
responses to heat include an increase in the blood flow to the skin (as much as
8 L/min), which is the major heat-dissipating organ; dilatation of the
peripheral venous system; and stimulation of the eccrine sweat glands to produce
more sweat.
As the major heat-dissipating organ, the skin can transfer heat to the
environment through conduction, convection, radiation, and evaporation.
Radiation is the most important mechanism of heat transfer at rest in temperate
climates, accounting for 65% of heat dissipation, and it can be modulated by
clothing. At high ambient temperatures, conduction becomes the least important
of the 4 mechanisms, while evaporation, which refers to the conversion of a
liquid to a gaseous phase, becomes the most effective mechanism of heat loss.
The efficacy of evaporation as a mechanism of heat loss depends on the
condition of the skin and sweat glands, the function of the lung, ambient
temperature, humidity, air movement, and whether or not the person is acclimated
to the high temperatures. For example, evaporation does not occur when the
ambient humidity exceeds 75% and is less effective in individuals who are not
acclimated. Nonacclimated individuals can only produce 1 L of sweat per hour,
which only dispels 580 kcal of heat per hour, whereas acclimated individuals can
produce 2-3 L of sweat per hour and can dissipate as much as 1740 kcal of heat
per hour through evaporation. Acclimatization to hot environments usually occurs
over 7-10 days and enables individuals to reduce the threshold at which sweating
begins, increase sweat production, and increase the capacity of the sweat glands
to reabsorb sweat sodium, thereby increasing the efficiency of heat dissipation.
When heat gain exceeds heat loss, the body temperature rises. Classic heat
stroke occurs in individuals who lack the capacity to modulate the environment
(eg, infants, elderly individuals, individuals who are chronically ill).
Furthermore, elderly persons and patients with diminished cardiovascular
reserves are unable to generate and cope with the physiologic responses to heat
stress and, therefore, are at risk of heat stroke. Patients with skin diseases
and those taking medications that interfere with sweating also are at increased
risk for heat stroke because they are unable to dissipate heat adequately.
Additionally, the redistribution of blood flow to the periphery, coupled with
the loss of fluids and electrolytes in sweat, place a tremendous burden on the
heart, which ultimately may fail to maintain an adequate cardiac output, leading
to additional morbidity and mortality.
Factors that interfere with heat dissipation include an inadequate
intravascular volume, cardiovascular dysfunction, and abnormal skin.
Additionally, high ambient temperatures, high ambient humidity, and many drugs
can interfere with heat dissipation, resulting in a major heat illness.
Similarly, hypothalamic dysfunction may alter temperature regulation and may
result in an unchecked rise in temperature and heat illness.
Frequency: Mortality/Morbidity: Morbidity and mortality from heat
stroke are related to the duration of the temperature elevation. When therapy is
delayed, the mortality rate may be as high as 80%; however, with early diagnosis
and immediate cooling, the mortality rate can be reduced to 10%. Mortality is
highest among the elderly population, patients with preexisting disease, those
confined to a bed, and those who are socially isolated.
Race: With the same risk factors and under the same
environmental conditions, heat stroke affects all races equally. However,
because of differences in social advantages, the annual death rate due to
environmental conditions is more than 3 times higher in blacks than in whites.
Sex: With the same risk factors and under the same
environmental conditions, heat stroke affects both genders equally. However,
because of gender differences in the workforce, the annual death rate due to
environmental conditions is 2 times higher in men than in women.
Age: Infants, children, and elderly persons have a higher
incidence of heat stroke than young, healthy adults.
CLINICAL
History:
Heat stroke is defined typically as hyperthermia exceeding 41°C and
anhidrosis associated with an altered sensorium. However, when a patient is
allowed to cool down prior to measurement of the temperature (as may occur
during transportation in a cool ambulance or evaluation in an emergency
department), the measured temperature may be much lower than 41°C, making the
temperature criterion relative. Similarly, some patients may retain the ability
to sweat, removing anhidrosis as a criterion for the diagnosis of heat stroke.
Therefore, strict adherence to the definition is not advised because it may
result in dangerous delays in diagnosis and therapy.
Clinically, 2 forms of heat stroke are differentiated. Classic heat stroke,
which occurs during environmental heat waves, is more common in very young
persons and in the elderly population and should be suspected in children,
elderly persons, and individuals who are chronically ill who present with an
altered sensorium. Classic heat stroke occurs because of failure of the body’s
heat dissipating mechanisms.
On the other hand, EHS affects young, healthy individuals who engage in
strenuous physical activity, and EHS should be suspected in all individuals with
bizarre irrational behavior or a history of syncope during strenuous exercise.
EHS results from increased heat production, which overwhelms the body’s ability
to dissipate heat.
Physical:
Causes:
DIFFERENTIALS
Closed head trauma
WORKUP
Lab Studies: Imaging Studies: Other Tests: Procedures:
TREATMENT
Medical Care:
Heat stroke is a medical emergency. Rapid reduction of the core body
temperature is the cornerstone of treatment because the duration of hyperthermia
is the primary determinant of outcome. Except for the mildest cases, patients
diagnosed with EHS or NEHS should be admitted to the hospital for at least 48
hours to monitor for complications.
Once heat stroke is suspected, cooling must begin immediately and must be
continued during the patient’s resuscitation. Removal of restrictive clothing
and spraying water on the body, covering the patient with ice water–soaked
sheets, or placing ice packs in the axillae and groin may reduce the patient's
temperature significantly. Patients who are unable to protect their airway
should be intubated. Patients who are awake and responsive should receive
supplemental oxygen. Intravenous lines may be placed in anticipation of fluid
resuscitation and for the infusion of dextrose and thiamine if indicated.
Hypoglycemia is a common occurrence in patients with EHS and may be a
manifestation of liver failure; therefore, infusion of dextrose 50% in water
solution (D50W) should be considered in all patients with heat stroke.
Surgical Care: Compartment syndrome must be suspected in all
patients who exhibit rhabdomyolysis and muscle edema and tenderness.
Intramuscular compartment pressure measurements must be performed when
compartment syndrome is suspected, and fasciotomy must be performed when the
intramuscular pressure exceeds 50 mm Hg. Fasciotomy also should be considered
when intracompartmental pressures are 30-50 mm Hg, especially when they show no
tendency to decrease in 6 hours and in patients who are hypotensive.
Consultations:
Diet: Patients may resume oral feeding when mental status,
swallowing, and gastrointestinal tract function are normal.
Activity: During the initial phase of therapy, neuromuscular
blockade with muscular paralysis should be considered for patients who are not
cooling adequately. Depolarizing agents (eg, succinylcholine) and inhaled
anesthetics should be avoided because of the risk of malignant hyperthermia.
Patients may resume activity when the temperature has stabilized.
MEDICATION
In treating heat
stroke, benzodiazepines play a major role in sedating patients, controlling
convulsions, and controlling shivering. Barbiturates (eg, phenobarbital) may be
used to control convulsions if benzodiazepines are not effective. Hypotension is
treated first with cooling and intravenous crystalloid fluids; dobutamine is
considered if patients are hypodynamic. Treatment of rhabdomyolysis involves
infusing large amounts of intravenous fluids (may require as much as 10 L),
alkalinization of urine, and mannitol infusion. Drug Category: Benzodiazepines -- Safe and
effective in controlling agitation, convulsions, and shivering.
FOLLOW-UP
Further Inpatient Care: Further Outpatient Care: Deterrence/Prevention: Complications: Prognosis: Patient Education:
MISCELLANEOUS
Medical/Legal Pitfalls:
Home page,
Drug information's
,Regional anesthesia
,Index for diseases
,Index for diseases,
Perioperative medicine,
Search engine,
Accreditation,
Learn Arabic
Warfare,
Anesthesia LINKS,
Orthopedic LINKS,
Midline Constructed
by Dr N.A. Nematallah Consultant in perioperative medicine and intensive
therapy, Al Razi Orthopedic Hospital ,
State of Kuwait, email : razianesth@freeservers.com
Delirium Tremens
Diabetic Ketoacidosis
Encephalopathy,
Hepatic
Encephalopathy, Uremic
Hyperthyroidism
Meningitis
Neuroleptic
Malignant Syndrome
Tetanus
Toxicity, Cocaine
Toxicity, Phencyclidine
Toxicity,
Salicylate
Other Problems to be Considered:
Malignant hyperthermia
Encephalitis
Cerebral
malaria
Cerebral hemorrhage
Amphetamine and cocaine toxicity
Strychnine
poisoning
Drug Name
Lorazepam (Ativan) -- Predictability and
ease of use make it DOC in most cases. May be used IV and is well absorbed
after IM injection. Onset of action is within minutes, effects peak in
15-20 min, and duration of action is 6-8 h.
Adult Dose
0.044 mg/kg IV; maximum rate 2 mg/min;
may repeat q15min until desired effect obtained or total of 8 mg
administered
Pediatric Dose
0.1 mg/kg IV; maximum rate 2 mg/min
Contraindications
Documented hypersensitivity; preexisting
CNS depression; hypotension; narrow-angle glaucoma
Interactions
Toxicity of benzodiazepines in CNS
increases when used concurrently with alcohol, phenothiazines,
barbiturates, and MAOIs; metabolism may be reduced by cimetidine or
nicotine
Pregnancy
D - Unsafe in pregnancy
Precautions
Caution in patients with renal or hepatic
impairment, myasthenia gravis, organic brain syndrome, Parkinson disease,
elderly patients, or cardiac disease
Drug Category:
Alkalinizing agents -- Indicated for severe acidosis and
rhabdomyolysis.
Drug Name
Midazolam (Versed) -- Rapidly acting
benzodiazepine with short duration. Ideal for sedation during short
procedures and may be effective in convulsions.
Adult Dose
0.01-0.05 mg/kg IV; may repeat q15min
until desired effect or total of 10 mg administered
Pediatric Dose
0.05-0.2 mg/kg IV
Contraindications
Documented hypersensitivity; preexisting
hypotension; narrow-angle glaucoma; sensitivity to propylene glycol (the
diluent)
Interactions
Sedative effects may be antagonized by
theophyllines; narcotics and erythromycin may accentuate sedative effects
due to decreased clearance; alcohol, other CNS depressants, cimetidine,
and nicotine may reduce metabolism, prolonging duration of effects
Pregnancy
D - Unsafe in pregnancy
Precautions
Caution in patients with congestive heart
failure, pulmonary disease, renal impairment, hepatic failure, and in
elderly patients
Drug Category:
Diuretics (osmotic) -- Osmotic effects retain water during urine
formation and dilute electrolytes in the urine, making resorption less
efficient.
Drug Name
Sodium bicarbonate (Neut) -- Useful in
alkalization of urine to prevent acute myoglobinuric renal failure. May be
administered as a bolus injection or as an infusion. The ideal solution to
which sodium bicarbonate is added should be hypotonic.
Adult Dose
Bolus: 1 mEq/kg IV
Infusion: Add
2-3 amp of sodium bicarbonate to 1000 cc of D5W and infuse at 200 cc/h;
maintain urine pH between 7.5-8.0
Pediatric Dose
Bolus: Administer as in adults, use
cautiously in children aged <2 y
Contraindications
Alkalosis; hypernatremia; hypocalcemia;
severe pulmonary edema; unknown abdominal pain
Interactions
Urinary alkalinization induced by
increased sodium bicarbonate concentrations may cause decreased levels of
lithium, tetracyclines, chlorpropamide, methotrexate, and salicylates;
increases levels of amphetamines, pseudoephedrine, flecainide,
anorexiants, mecamylamine, ephedrine, quinidine, and quinine
Pregnancy
C - Safety for use during pregnancy has
not been established.
Precautions
Can cause alkalosis, decreased plasma
potassium, hypocalcemia, and hypernatremia; caution in electrolyte
imbalances such as patients with CHF, cirrhosis, edema, corticosteroid
use, or renal failure; when administering, avoid extravasation because
tissue necrosis can result
Drug Category: Adrenergic agonist agents -- Produce
vasodilation and increase inotropic state.
Drug Name
Mannitol (Osmitrol) -- DOC for forced
diuresis in patients with rhabdomyolysis because of a number of beneficial
effects on the kidneys, including an antioxidant effect.
Adult Dose
25-100 g IV infused over 1-2 h
Pediatric Dose
Not established
Contraindications
Documented hypersensitivity; anuria;
severe pulmonary congestion; progressive renal damage; severe dehydration;
active intracranial bleeding; progressive heart failure
Interactions
May decrease serum lithium levels
Pregnancy
C - Safety for use during pregnancy has
not been established.
Precautions
Carefully evaluate cardiovascular status
before rapid administration of mannitol because a sudden increase in
extracellular fluid may lead to fulminating CHF
Drug Name
Dobutamine (Dobutrex) -- Synthetic
compound structurally similar to catecholamines. DOC for circulatory
support in heat stroke.
Adult Dose
2-20 mcg/kg/min IV infusion
Pediatric Dose
Administer as in adults
Contraindications
Documented hypersensitivity; idiopathic
hypertrophic subaortic stenosis; atrial fibrillation or flutter
Interactions
Beta-adrenergic blockers antagonize
effects of dobutamine; general anesthetics may increase toxicity
Pregnancy
B - Usually safe but benefits must
outweigh the risks.
Precautions
Following a myocardial infarction, use
with extreme caution; correct hypovolemic state before
using